HOME >> BIOLOGY >> NEWS
Sequenced malaria genome exposes novel drug targets

The genetic code of the malaria parasite has been cracked and is already revealing novel drug targets that could lead to effective treatment of the disease.

An international effort was launched in 1996 to sequence the genome of the most deadly malaria species, Plasmodium falciparum. Botanists from the University of Melbourne are now leading the charge to help find safe and effective anti-malarial drugs.

Professor Geoff McFadden and his team from the University of Melbourne recently discovered that the malaria parasite evolved from a plant-like organism that survived by photosynthesis. It is this plant-like part that, so far, appears to be a depot for anti-malarial drug targets. Consequently, existing safe herbicides are providing leads for some of these new drugs. So too are antibiotics.

"Our role in this international collaboration is to find the genes associated with the relict plant component of the parasite. This has been a key success of the study. At least 12 new drug targets have been identified so far from the plant-like genes" says McFadden.

The collaboration's research, including the complete sequence of the malaria parasite, is published in the latest edition of the prestigious journal Nature.

Human malaria is caused by infection with parasites of the Plasmodium species that are transmitted by Anopheles mosquitoes.

Plasmodium species are members of large group numbering over 5000 species that harbour a relict chloroplast, the part of a plant that carries out photosynthesis. Scientists have determined this relict, called the apicoplast, is essential for the malaria parasite's survival, but its exact role is unclear.

McFadden's team has gone someway to unraveling the apicoplast's mysteries. They have revealed that it is the apicoplast that houses the herbicide-sensitive pathways and compounds with potential for drug therapy. Stuart Ralph, a PhD student in McFadden's lab, has helped identify th
'"/>

Contact: Jason Major
jmajor@unimelb.edu.au
61-3-8344-0181
University of Melbourne
3-Oct-2002


Page: 1 2 3

Related biology news :

1. Master of antimalarial resistance
2. Improved nutrition could reduce malaria burden worldwide
3. Antimalarial substances found in New Caledonian sponges
4. Inadequate vaccines can help breed more vicious malaria strains
5. Discovery in parasite movement may offer insights into malaria
6. Plant-like enzyme acts as key life cycle switch in malaria parasite
7. First target for childhood malaria vaccine
8. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
9. Mosquitoes vs. malaria: How we can win the fight
10. New, non-radioactive screen for antimalarial compounds
11. New advance to combat antibiotic-resistant pneumonia and malaria

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/4/2019)... N.J. (PRWEB) , ... August 02, 2019 , ... ... to assist the life science industry in advancing the development of medical therapies, ... been recognized by PharmaVOICE magazine as one of the “100 Most Inspiring People ...
(Date:8/1/2019)... SAN JOSE, Calif. (PRWEB) , ... July 31, ... ... and cell biology technologies, today announced the launch of the next generation of ... builds on the success of the industry-leading FLIPR® platform for monitoring of G-protein-coupled ...
(Date:7/26/2019)... ANGELES (PRWEB) , ... July 25, 2019 , ... ... platform, today announced the first mixed reality headsets to include a new generation ... SIGGRAPH 2019 Exhibition in Los Angeles, California (July 30 - August 1). ...
Breaking Biology News(10 mins):
(Date:8/6/2019)... ... August 05, 2019 , ... ... been recognized as a distinguished leader by PharmaVOICE magazine, earning him a prestigious ... in the magazine’s July/August special issue. , As the executive vice president of ...
(Date:7/23/2019)... , ... July 22, 2019 , ... ... companies with best-in-class services in the fields of 3D tissue imaging , ... learning , Visikol initially started back in 2013 as a products company. These ...
(Date:7/17/2019)... ... July 16, 2019 , ... Quidel is ... from Kalorama Information. Abbott, Roche and Siemens Healthineers and Response Biomedical also are ... Worldwide Market for Point-of-Care (POC) Diagnostics . , Quidel is a market ...
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research results from ... of Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The ... peak, change in crystallite size , Over 142% increase in particle size ...
Breaking Biology Technology:
Cached News: